Connor, Clark & Lunn Investment Management (CC&L)
SPPI

Connor, Clark & Lunn Investment Management (CC&L)’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,996
Closed -$97K – 1258
2021
Q2 		$97K Buy
+25,996
New +$90.3K ﹤0.01% 946
2021
Q1 		– Sell
-76,745
Closed -$262K – 1125
2020
Q4 		$262K Buy
+76,745
New +$316K ﹤0.01% 798
2020
Q3 		– Sell
-255,880
Closed -$865K – 1170
2020
Q2 		$865K Sell
255,880
-87,994
-26% -$256K 0.01% 644
2020
Q1 		$801K Buy
343,874
+141,049
+70% +$386K 0.01% 608
2019
Q4 		$738K Sell
202,825
-5,525
-3% -$44.6K 0.01% 599
2019
Q3 		$1.73M Buy
208,350
+31,225
+18% +$253K 0.01% 439
2019
Q2 		$1.52M Buy
177,125
+148,575
+520% +$1.33M 0.01% 498
2019
Q1 		$305K Buy
+28,550
New +$306K ﹤0.01% 753
2018
Q4 		– Sell
-50,790
Closed -$853K – 1068
2018
Q3 		$853K Buy
+50,790
New +$1.1M ﹤0.01% 593
2017
Q2 		– Sell
-108,304
Closed -$704K – 984
2017
Q1 		$704K Sell
108,304
-94,396
-47% -$528K ﹤0.01% 561
2016
Q4 		$898K Sell
202,700
-9,600
-5% -$40.3K 0.01% 506
2016
Q3 		$991K Sell
212,300
-121,800
-36% -$722K 0.01% 468
2016
Q2 		$2.19M Sell
334,100
-87,625
-21% -$619K 0.02% 354
2016
Q1 		$2.68M Sell
421,725
-191,800
-31% -$984K 0.02% 299
2015
Q4 		$3.7M Buy
613,525
+233,225
+61% +$1.33M 0.03% 247
2015
Q3 		$2.27M Buy
380,300
+342,200
+898% +$2.38M 0.02% 287
2015
Q2 		$261K Buy
38,100
+6,700
+21% +$42.5K ﹤0.01% 516
2015
Q1 		$191K Buy
31,400
+5,300
+20% +$35.3K ﹤0.01% 507
2014
Q4 		$181K Buy
+26,100
New +$192K ﹤0.01% 533

Other funds holding SPPI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SPPI Position: Q3 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2021, closing a stake of 25,996 shares — an estimated $97K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SPPI in Q4 2014 and held it in 19 quarters. The position peaked at $3.7M in Q4 2015. 147 funds tracked by Wall St. Rank hold SPPI as of Q3 2021.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 25,996 Spectrum Pharmaceuticals Inc shares in Q3 2021, an estimated $97K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 19 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Spectrum Pharmaceuticals Inc position peaked at $3.7M in Q4 2015.
  • 147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2021, filed 12 Nov 2021.